Express Pharma
Home  »  Archive  »  DISSO ASIA 2014 held in Mumbai

DISSO ASIA 2014 held in Mumbai

0 11
Read Article

Society for Pharmaceutical Dissolution Science (SPDS) conducted its 2nd Annual International Convention DISSO ASIA 2014 on 5-6 May 2014 at The Lalit in Mumbai. The event promoted introduction of new technology and innovation apart from deliberating on various issues related to dissolution. DISSO ASIA 2014 was attended by eminent professionals from the pharma industry.

This event was organised under the Chairmanship of Dr Nandakumar Chodankar, CEO & Promoter (Director on Board), ASolution Pharmaceuticals and the Organising Secretary, Dr L Ramaswamy, Managing Director, Sotax India. The scientific sessions were programmed and executed under the chairmanship of Dr Mangal Nagarsenker, HOD & Professor of Pharmaceutics, Bombay College of Pharmacy, and Mumbai.

The International Symposium was inaugurated by Dr GD Yadav, Vice Chancellor, Institute of Chemical Technology ( ICT ), Mumbai.

Dr Vatlamudi Rao, current President of Indian Pharmaceutical Association (IPA) was the Guest of Honor. In his address he expressed that IPA shall support SPDS and may organise collaborative programmes across the country.

At this occasion, SPDS published a Desk Book of Pharmaceutical Dissolution Science reportedly written by more than 10 eminent authors and edited by Dr Sandeep Tiwari, Dr.Umesh Banakar, and Dr Vinod Shah.

Around 150 delegates from industry and academia attended the event. Sotax India was the Platinum Partner of the event.

Dr Vinod Shah and Dr Umesh Banakar were awarded with the SPDS excellence award for contribution to the field of Dissolution Science

The event comprised:

Plenary Lecture, Poster Exhibits, Panel Discussion, Exhibits

The event had global speakers who spoke on a variety of topics:

Vijay Kshirsagar, Director & CEO, TRAC Consulting, Mumbai spoke on ‘Relevance of Current Batch Centric BE Studies’

Dr Vinod Shah, Ex US FDA, Pharmaceutical Consultant, US enlightened on ‘FDA/USP Perspectives on Dissolution Testing from Regulatory Filing Point of View’

Prof Dr Jean Michel Cardot, Professor, Department of Biopharmaceutics, and Pharmaceutical Technology, Auvergne University, France elaborated on ‘In-Vitro Dissolution as In-Vivo Surrogate’

Samir Haddouchi, Managing Director, SPS Pharma Services, Clermont Ferrand – France gave an ‘Overview of Challenges and Solutions to Dissolution Testing of Non-Oral Formulations’

Dr Umesh Banakar, Professor and President, Banakar Consultancy Services, US spoke on the topic, ‘Biosimilars – The Emerging Frontier for Generics: Role of Dissolution Testing’

Michel Magnier, Product Manager/Application Specialist, SOTAX AG explained about ‘Automation for Dissolution Testing’

Bryan Crist, Manager, Scientific Affairs, Agilent technologies, US spoke about ‘Validation of Components and data of Automated Dissolution Methods’

Prof Dr Sompol Prakongpan, Professor of Pharmacy, Burapha University, Thailand expounded on ‘Biowaiver of Biopharmaceutics Classification System Class III Drug Products’

Dr Sid Bhoopathy, Chief Operating Officer, Absorption Systems, US gave an insight on ‘Strategies for Establishing Equivalence of Complex Drug Products’

Dr Flavian Stefan Radulescu, University of Medicine and Pharmacy “Carol Davila” Bucharest, Romania elaborated on the ‘Correlation between rheology, in-vitro release and in- vivo performance of topical dosage forms’

A panel discussion on ‘Handling Dissolution Challenges’ was also held and eminent professionals from the pharma industry participated in it.

DISSO ASIA 2014 was specifically designed for all the professionals from R&D, QA and QC as well as the academia. Next year SPDS is planning to organise Disso America in US.

EP News BureauMumbai

Leave A Reply

Your email address will not be published.